Skip to main content

Table 3 Intergroup comparison for dialysis patients according to AVC level at baseline ( n= 67)

From: Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study

  

No AVC

Present AVC

N

[n;%]

40; 60%

27; 40%

Gender (male)

[n;%]

19; 48%

13; 48%

Age

[yrs]

57 ± 16

63 ± 13

Time since first dialysis [mo]

 

76 ± 85

79 ± 81

BMI

[kg/m2]

25 ± 5

26 ± 7

CAC Agatston

 

507 ± 794

918 ± 938

AVC Agatson

 

0 ± 0

189 ± 340

ucMGP

[nmol/L]

2366 ± 791

2261 ± 589

Fetuin-A

[g/L]

0.46 ± 0.11

0.46 ± 0.07

OPG

[pmol/L]

4.96 ± 2.60

5.63 ± 2.819

Sclerostin

[ng/mL]

1.35 ± 0.73

1.78 ± 0.84

CRP

[mg/L]

7.77 ± 7.78

5.65 ± 4.55

iPTH

[pg/mL]

242 ± 350

190 ± 301

BAP

[U/L]

36 ± 30

27 ± 18

AP

[U/L]

91 ± 60

79 ± 66

Total Ca2+

[mmol/L]

2.39 ±0.21

2.27 ± 0.36

Phosphorus

[mmol/L]

1.76 ± 0.47

1.95 ± 0.63

Albumin

[g/L]

39 ± 7

39 ± 4

Hb

[g/L]

111 ± 14

108 ± 32

S-Creatinine

[mg/dL]

9.2 ± 2.9

9.8 ± 3.0

S-Urea

[mmol/L]

65 ± 59

81 ± 63